Therefore, CXCR6 could well be a functional marker for the Th17-type effector, but that CXCR6 deficiency would not affect the development of colitis in a Th1-dominant model such as the CD4+CD45RBhigh cell-transferred model. This evidence concerns the gene CXCR6 and colitis.